Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors

CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 w...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 9; no. 6; p. e100178
Main Authors: Keleg, Shereen, Titov, Alexandr, Heller, Anette, Giese, Thomas, Tjaden, Christine, Ahmad, Sufian S, Gaida, Matthias M, Bauer, Andrea S, Werner, Jens, Giese, Nathalia A
Format: Journal Article
Language:English
Published: United States Public Library of Science 16-06-2014
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue(high)/sera(low)-discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic 'drop and restoration' alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration.
AbstractList CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue.sup.high /sera.sup.low -discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic 'drop and restoration' alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration.
CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (s CSPG4 ) might circulate and reflect potential changes in CSPG4 tissue expression (p CSPG4 ) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum s CSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic p CSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. s CSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic p CSPG4 expression was preserved or elevated, whereby neoplastic cells lacked p CSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue high /sera low -discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which p VHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined p CSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed p CSPG4 -responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4 , is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic ‘drop and restoration’ alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration.
CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue(high)/sera(low)-discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic 'drop and restoration' alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration.
CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissuehigh/seralow-discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic ‘drop and restoration’ alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration.
Audience Academic
Author Titov, Alexandr
Tjaden, Christine
Gaida, Matthias M
Werner, Jens
Giese, Thomas
Ahmad, Sufian S
Keleg, Shereen
Heller, Anette
Bauer, Andrea S
Giese, Nathalia A
AuthorAffiliation 4 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
The Liverpool Cancer Research UK Centre, United Kingdom
2 Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany
3 Department of Functional Genomics, German Cancer Research Centre, Heidelberg, Germany
1 European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
AuthorAffiliation_xml – name: 4 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
– name: 3 Department of Functional Genomics, German Cancer Research Centre, Heidelberg, Germany
– name: 2 Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany
– name: 1 European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
– name: The Liverpool Cancer Research UK Centre, United Kingdom
Author_xml – sequence: 1
  givenname: Shereen
  surname: Keleg
  fullname: Keleg, Shereen
  organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
– sequence: 2
  givenname: Alexandr
  surname: Titov
  fullname: Titov, Alexandr
  organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
– sequence: 3
  givenname: Anette
  surname: Heller
  fullname: Heller, Anette
  organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
– sequence: 4
  givenname: Thomas
  surname: Giese
  fullname: Giese, Thomas
  organization: Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany
– sequence: 5
  givenname: Christine
  surname: Tjaden
  fullname: Tjaden, Christine
  organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
– sequence: 6
  givenname: Sufian S
  surname: Ahmad
  fullname: Ahmad, Sufian S
  organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
– sequence: 7
  givenname: Matthias M
  surname: Gaida
  fullname: Gaida, Matthias M
  organization: Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
– sequence: 8
  givenname: Andrea S
  surname: Bauer
  fullname: Bauer, Andrea S
  organization: Department of Functional Genomics, German Cancer Research Centre, Heidelberg, Germany
– sequence: 9
  givenname: Jens
  surname: Werner
  fullname: Werner, Jens
  organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
– sequence: 10
  givenname: Nathalia A
  surname: Giese
  fullname: Giese, Nathalia A
  organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24932730$$D View this record in MEDLINE/PubMed
BookMark eNqNk11v0zAUhiM0xD7gHyCIhITgosWOndi5QZoqGJUmDTHg1nKck9bFtTPbqbZ_j7tmU4t2gXzh6Pg573l94nOaHVlnIcteYzTFhOFPKzd4K820T-Epwghhxp9lJ7gmxaQqEDna-z7OTkNYIVQSXlUvsuOCphNG0EkmZktnW-901DYPg-lkhLz3LoJbmDslbT67_n5BcxlymVu3AZMv73p3q-UkgA0pbQP5Wvo_4POk0EurPMioVR6HtfPhZfa8kybAq3E_y359_fJz9m1yeXUxn51fThQreUwmVbJZlbikkgHwpuNNQxkvaFVIWtWNojUgDsCA0bpoGSGMc2hwxyuCqCRn2dudbm9cEGNvgsAlqRCvS14kYr4jWidXovc6ub4TTmpxH3B-IaRPxg2IUgGgsu4ahQgt65YnCcbbNnmtgdfbap_HakOzhlaBjV6aA9HDE6uXYuE2giZZRrdmPowC3t0MEKJY66DAGGnBDfe-GU4gogl99w_69O1GaiHTBbTtXKqrtqLinGJOi7RwoqZPUGm1sNYqPaROp_hBwseDhMREuI0LOYQg5tc__p-9-n3Ivt9jlyBNXAZnhqidDYcg3YHKuxA8dI9Nxkhs5-ChG2I7B2Kcg5T2Zv8HPSY9PHzyF8z2A9Q
CitedBy_id crossref_primary_10_3390_cancers14225564
crossref_primary_10_1016_j_jprot_2018_07_015
crossref_primary_10_1021_acs_chemrev_8b00354
crossref_primary_10_18632_oncotarget_24312
crossref_primary_10_3390_vaccines10071023
crossref_primary_10_1371_journal_ppat_1011272
crossref_primary_10_2183_pjab_100_019
crossref_primary_10_1186_s11658_017_0035_3
crossref_primary_10_1371_journal_pone_0145584
crossref_primary_10_1186_s12896_015_0218_9
crossref_primary_10_1186_s12967_022_03679_y
crossref_primary_10_1002_ijc_31087
crossref_primary_10_1016_j_ctrv_2021_102193
crossref_primary_10_1016_j_matbio_2017_10_008
crossref_primary_10_1177_03009858241244853
crossref_primary_10_1186_s12967_017_1250_4
crossref_primary_10_3892_ol_2023_13968
crossref_primary_10_1038_s41598_023_32528_1
Cites_doi 10.1038/nrgastro.2011.114
10.1097/mpa.0b013e31805d0190
10.1016/S0140-6736(03)13643-4
10.1073/pnas.0900465106
10.1159/000147846
10.1016/j.cgh.2008.05.006
10.1371/journal.pone.0023062
10.1053/j.gastro.2007.01.031
10.1126/science.1195300
10.1023/A:1025731428581
10.1007/s00535-011-0482-y
10.1016/j.tibs.2012.06.004
10.1182/blood.V87.3.1123.bloodjournal8731123
10.1053/j.gastro.2012.03.002
10.1091/mbc.6.12.1819
10.1016/S0002-9440(10)63971-5
10.1038/372679a0
10.1158/1078-0432.CCR-13-2218
10.1073/pnas.1312570111
10.3109/14653249.2011.651528
10.1016/j.ccr.2007.02.020
10.1097/01.MP.0000094088.37888.A6
10.1053/j.gastro.2008.09.029
10.1242/dev.00837
10.4161/isl.2.3.11449
10.1073/pnas.0912589107
10.1016/0016-5085(91)90026-H
10.1016/S0002-9440(10)64799-2
10.1007/s00401-011-0867-2
10.1097/SLA.0b013e31828cd008
10.1038/nm.2344
10.1073/pnas.1001296107
10.1159/000094833
10.1007/s00428-004-1053-x
10.18632/oncotarget.1291
10.1016/S0002-9440(10)63053-2
10.1371/journal.pone.0084883
10.1097/SLA.0b013e31821fd334
10.1136/gut.2010.232272
10.1007/s00109-009-0504-x
10.1038/nrc3183
10.2174/13816128112092395
10.1016/j.devcel.2011.07.001
10.1016/j.surg.2011.05.011
10.1128/MCB.01621-07
10.1002/path.2348
10.1111/j.1741-4520.2010.00307.x
10.1016/S0016-5085(98)70209-4
10.1073/pnas.0810097105
10.1136/gut.2010.226092
10.1038/onc.2008.157
10.1016/j.ccr.2005.07.015
10.1097/01.MP.0000075645.97329.86
10.1167/iovs.05-0559
10.1016/j.pan.2012.04.004
10.1158/1078-0432.CCR-1190-03
10.1371/journal.pbio.1001143
10.1002/path.3017
10.1053/j.gastro.2007.09.009
ContentType Journal Article
Copyright COPYRIGHT 2014 Public Library of Science
2014 Keleg et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2014 Keleg et al 2014 Keleg et al
Copyright_xml – notice: COPYRIGHT 2014 Public Library of Science
– notice: 2014 Keleg et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2014 Keleg et al 2014 Keleg et al
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0100178
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Opposing Viewpoints Resource Center
Gale in Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
Technology Collection
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agriculture Science Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
ProQuest Engineering Database
Nursing & Allied Health Premium
ProQuest Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Biological Science Collection
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
Technology Collection
Technology Research Database
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE


Agricultural Science Database

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate CSPG4 in Pancreatic Tumors
EISSN 1932-6203
Editor Costello, Eithne
Editor_xml – sequence: 1
  givenname: Eithne
  surname: Costello
  fullname: Costello, Eithne
EndPage e100178
ExternalDocumentID 1536089582
oai_doaj_org_article_5cee059fbc03459d808978ddc759e89a
3335849471
A418424241
10_1371_journal_pone_0100178
24932730
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BBORY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CGR
CS3
CUY
CVF
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
ECM
EIF
EMOBN
ESTFP
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
IOV
IPNFZ
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
NPM
O5R
O5S
OK1
P2P
P62
PATMY
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RIG
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
AAYXX
CITATION
AFPKN
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PQEST
PQUKI
PRINS
RC3
7X8
5PM
AAPBV
ABPTK
N95
ID FETCH-LOGICAL-c758t-62c20365154a7ee8bf8bb4782462a469bc49e08ee7e7492d733788eb1f86304a3
IEDL.DBID RPM
ISSN 1932-6203
IngestDate Sun Apr 02 01:15:41 EDT 2023
Tue Oct 22 15:06:38 EDT 2024
Tue Sep 17 20:45:21 EDT 2024
Fri Oct 25 09:22:12 EDT 2024
Thu Oct 10 20:34:31 EDT 2024
Tue Nov 19 20:39:51 EST 2024
Tue Nov 12 22:34:37 EST 2024
Thu Aug 01 20:24:19 EDT 2024
Thu Aug 01 19:35:39 EDT 2024
Tue Aug 20 22:05:03 EDT 2024
Thu Nov 21 22:45:01 EST 2024
Tue Oct 15 23:50:16 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-62c20365154a7ee8bf8bb4782462a469bc49e08ee7e7492d733788eb1f86304a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: SK AT AH CT JW NAG. Performed the experiments: SK AT AH TG SSA NAG. Analyzed the data: SK AT MMG JW NAG. Contributed reagents/materials/analysis tools: TG ASB CT JW. Wrote the paper: SK NAG.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059742/
PMID 24932730
PQID 1536089582
PQPubID 1436336
ParticipantIDs plos_journals_1536089582
doaj_primary_oai_doaj_org_article_5cee059fbc03459d808978ddc759e89a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4059742
proquest_miscellaneous_1537174204
proquest_journals_1536089582
gale_infotracmisc_A418424241
gale_infotracacademiconefile_A418424241
gale_incontextgauss_ISR_A418424241
gale_incontextgauss_IOV_A418424241
gale_healthsolutions_A418424241
crossref_primary_10_1371_journal_pone_0100178
pubmed_primary_24932730
PublicationCentury 2000
PublicationDate 2014-06-16
PublicationDateYYYYMMDD 2014-06-16
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-06-16
  day: 16
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2014
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References 23532108 - Ann Surg. 2013 Jul;258(1):141-51
20966025 - Gut. 2011 Jun;60(6):861-8
20660313 - Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14182-7
14501214 - J Neurocytol. 2002 Jul-Aug;31(6-7):423-35
21750515 - Nat Rev Gastroenterol Hepatol. 2011 Aug;8(8):467-72
18227155 - Mol Cell Biol. 2008 Apr;28(7):2414-25
18054571 - Gastroenterology. 2007 Dec;133(6):1999-2009
12814730 - Lancet. 2003 Jun 14;361(9374):2059-67
2065922 - Gastroenterology. 1991 Aug;101(2):465-71
15258755 - Virchows Arch. 2004 Sep;445(3):236-47
17895840 - Pancreas. 2007 Oct;35(3):212-7
17408641 - Gastroenterology. 2007 Apr;132(4):1447-64
21984419 - J Pathol. 2012 Apr;226(5):723-34
22687371 - Pancreatology. 2012 May-Jun;12(3):183-97
22169972 - Nat Rev Cancer. 2012 Jan;12(1):9-22
19629420 - J Mol Med (Berl). 2009 Sep;87(9):871-7
18469852 - Oncogene. 2008 Sep 4;27(39):5182-94
21508421 - Gut. 2011 Dec;60(12):1712-20
22406637 - Gastroenterology. 2012 May;142(5):1079-92
16888406 - Ophthalmic Res. 2006;38(5):251-4
19541609 - Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11137-42
18992743 - Gastroenterology. 2009 Jan;136(1):177-186.e1
8669463 - Am J Pathol. 1996 Jun;148(6):1763-70
21606835 - Ann Surg. 2011 Aug;254(2):311-9
21909240 - PLoS Biol. 2011 Sep;9(9):e1001143
24334762 - Clin Cancer Res. 2014 Feb 15;20(4):962-71
24604757 - J Pathol. 2014 Jul;233(3):217-27
18639493 - Clin Gastroenterol Hepatol. 2008 Oct;6(10):1155-61
23474557 - JOP. 2013 Mar;14(2):141-4
16169464 - Cancer Cell. 2005 Sep;8(3):185-95
9679048 - Gastroenterology. 1998 Aug;115(2):421-32
24127551 - Oncotarget. 2013 Sep;4(9):1527-46
21099310 - Islets. 2010 May-Jun;2(3):164-73
11141506 - Am J Pathol. 2001 Jan;158(1):317-21
7990960 - Nature. 1994 Dec 15;372(6507):679-83
22041919 - J Gastroenterol. 2012 Feb;47(2):203-13
22699001 - Eur J Cell Biol. 2012 Nov-Dec;91(11-12):969-77
18421760 - J Pathol. 2008 Jun;215(2):195-203
21051638 - Science. 2010 Nov 5;330(6005):827-30
9117258 - Perspect Dev Neurobiol. 1996;3(4):245-59
9124036 - Acta Anat (Basel). 1996;156(3):187-201
17349578 - Cancer Cell. 2007 Mar;11(3):211-3
21719059 - Surgery. 2011 Aug;150(2):306-15
11733352 - Am J Pathol. 2001 Dec;159(6):2017-22
21129040 - Congenit Anom (Kyoto). 2011 Mar;51(1):21-5
21829586 - PLoS One. 2011;6(7):e23062
14573520 - Development. 2003 Dec;130(24):6049-63
22277011 - Cytotherapy. 2012 May;14(5):608-20
22372500 - Curr Pharm Des. 2012;18(17):2395-403
21839917 - Dev Cell. 2011 Aug 16;21(2):193-215
12861065 - Mod Pathol. 2003 Jul;16(7):686-91
15269152 - Clin Cancer Res. 2004 Jul 15;10(14):4776-83
8590808 - Mol Biol Cell. 1995 Dec;6(12):1819-32
16303921 - Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4365-71
21460848 - Nat Med. 2011 Apr;17(4):500-3
22818162 - Trends Biochem Sci. 2012 Sep;37(9):364-72
24386429 - PLoS One. 2013;8(12):e84883
21863242 - Acta Neuropathol. 2011 Oct;122(4):495-510
14614047 - Mod Pathol. 2003 Nov;16(11):1086-94
20018761 - Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):75-80
24550282 - Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2554-9
11073821 - Am J Pathol. 2000 Nov;157(5):1615-21
8562938 - Blood. 1996 Feb 1;87(3):1123-33
19028870 - Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18913-8
Y Li (ref17) 2005; 46
F Girolamo (ref19) 2013; 8
GO Ceyhan (ref3) 2009; 136
EA Collisson (ref38) 2011; 17
B Faubert (ref37) 2014; 111
O Strobel (ref45) 2007; 133
SG Kim (ref59) 2003; 16
A Armulik (ref6) 2011; 21
D Pankova (ref13) 2012
HP Neumann (ref33) 1991; 101
M Erkan (ref2) 2008; 6
RR Lonser (ref52) 2003; 361
M Erkan (ref23) 2007; 132
U Ozerdem (ref18) 2006; 38
J Koninger (ref24) 2004; 10
JM Levine (ref8) 1996; 3
J Legg (ref9) 2003; 130
F Carlotti (ref10) 2010; 2
A Neesse (ref21) 2011; 60
J Mazumdar (ref42) 2010; 107
A Poli (ref63) 2013; 4
M Chekenya (ref15) 2008; 27
M Kraman (ref5) 2010; 330
K Stark (ref54) 1994; 372
L Landsman (ref57) 2011; 9
LC Murtaugh (ref46) 2007; 11
A Nishiyama (ref20) 1995; 6
WB Stallcup (ref11) 2002; 31
E Amato (ref30) 2014
T Furukawa (ref25) 1996; 148
M Mino-Kenudson (ref27) 2011; 60
N Habbe (ref47) 2008; 105
C Geldres (ref64) 2014; 20
B Kong (ref43) 2011; 8
BZ Stanger (ref48) 2005; 8
M Tanaka (ref28) 2012; 12
H Arafat (ref32) 2011; 150
Y Higuchi (ref58) 2011; 51
F Konstantinou (ref29) 2013; 14
PS Moore (ref60) 2001; 158
M Bartel (ref26) 2008; 215
FO Smith (ref12) 1996; 87
MG Bachem (ref22) 1998; 115
J Wang (ref16) 2011; 6
I Esposito (ref50) 2007; 35
MY Koh (ref41) 2012; 37
PA Perez-Mancera (ref44) 2012; 142
M Aichler (ref49) 2012; 226
MS Wiesener (ref53) 2009; 87
M Rovira (ref51) 2010; 107
N Ideno (ref39) 2013; 258
D Mohri (ref31) 2012; 47
VH Mohr (ref34) 2000; 157
DB Shackelford (ref36) 2009; 106
B Keith (ref40) 2012; 12
N Sato (ref61) 2001; 159
AF Hezel (ref35) 2008; 28
H Liu (ref4) 2012; 18
PJ Ju (ref7) 2012; 14
A Svendsen (ref14) 2011; 122
JA Davies (ref55) 1996; 156
F Sahin (ref62) 2003; 16
P Monti (ref56) 2004; 445
W Hartwig (ref1) 2011; 254
References_xml – volume: 8
  start-page: 467
  year: 2011
  ident: ref43
  article-title: From tissue turnover to the cell of origin for pancreatic cancer
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2011.114
  contributor:
    fullname: B Kong
– volume: 35
  start-page: 212
  year: 2007
  ident: ref50
  article-title: Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment
  publication-title: Pancreas
  doi: 10.1097/mpa.0b013e31805d0190
  contributor:
    fullname: I Esposito
– volume: 361
  start-page: 2059
  year: 2003
  ident: ref52
  article-title: von Hippel-Lindau disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)13643-4
  contributor:
    fullname: RR Lonser
– volume: 106
  start-page: 11137
  year: 2009
  ident: ref36
  article-title: mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0900465106
  contributor:
    fullname: DB Shackelford
– volume: 156
  start-page: 187
  year: 1996
  ident: ref55
  article-title: Mesenchyme to epithelium transition during development of the mammalian kidney tubule
  publication-title: Acta Anat (Basel)
  doi: 10.1159/000147846
  contributor:
    fullname: JA Davies
– volume: 6
  start-page: 1155
  year: 2008
  ident: ref2
  article-title: The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2008.05.006
  contributor:
    fullname: M Erkan
– volume: 6
  start-page: e23062
  year: 2011
  ident: ref16
  article-title: Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0023062
  contributor:
    fullname: J Wang
– volume: 132
  start-page: 1447
  year: 2007
  ident: ref23
  article-title: Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.01.031
  contributor:
    fullname: M Erkan
– volume: 330
  start-page: 827
  year: 2010
  ident: ref5
  article-title: Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha
  publication-title: Science
  doi: 10.1126/science.1195300
  contributor:
    fullname: M Kraman
– volume: 31
  start-page: 423
  year: 2002
  ident: ref11
  article-title: The NG2 proteoglycan: past insights and future prospects
  publication-title: J Neurocytol
  doi: 10.1023/A:1025731428581
  contributor:
    fullname: WB Stallcup
– volume: 47
  start-page: 203
  year: 2012
  ident: ref31
  article-title: Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-011-0482-y
  contributor:
    fullname: D Mohri
– volume: 37
  start-page: 364
  year: 2012
  ident: ref41
  article-title: Passing the baton: the HIF switch
  publication-title: Trends Biochem Sci
  doi: 10.1016/j.tibs.2012.06.004
  contributor:
    fullname: MY Koh
– volume: 87
  start-page: 1123
  year: 1996
  ident: ref12
  article-title: The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23
  publication-title: Blood
  doi: 10.1182/blood.V87.3.1123.bloodjournal8731123
  contributor:
    fullname: FO Smith
– volume: 142
  start-page: 1079
  year: 2012
  ident: ref44
  article-title: What we have learned about pancreatic cancer from mouse models
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2012.03.002
  contributor:
    fullname: PA Perez-Mancera
– volume: 6
  start-page: 1819
  year: 1995
  ident: ref20
  article-title: Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.6.12.1819
  contributor:
    fullname: A Nishiyama
– volume: 158
  start-page: 317
  year: 2001
  ident: ref60
  article-title: Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63971-5
  contributor:
    fullname: PS Moore
– volume: 372
  start-page: 679
  year: 1994
  ident: ref54
  article-title: Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4
  publication-title: Nature
  doi: 10.1038/372679a0
  contributor:
    fullname: K Stark
– volume: 20
  start-page: 962
  year: 2014
  ident: ref64
  article-title: T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-13-2218
  contributor:
    fullname: C Geldres
– volume: 111
  start-page: 2554
  year: 2014
  ident: ref37
  article-title: Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1alpha
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1312570111
  contributor:
    fullname: B Faubert
– volume: 14
  start-page: 608
  year: 2012
  ident: ref7
  article-title: Clonal analysis for elucidating the lineage potential of embryonic NG2+ cells
  publication-title: Cytotherapy
  doi: 10.3109/14653249.2011.651528
  contributor:
    fullname: PJ Ju
– volume: 11
  start-page: 211
  year: 2007
  ident: ref46
  article-title: A case of mistaken identity? Nonductal origins of pancreatic “ductal” cancers
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2007.02.020
  contributor:
    fullname: LC Murtaugh
– volume: 16
  start-page: 1086
  year: 2003
  ident: ref59
  article-title: Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas
  publication-title: Mod Pathol
  doi: 10.1097/01.MP.0000094088.37888.A6
  contributor:
    fullname: SG Kim
– volume: 136
  start-page: 177
  year: 2009
  ident: ref3
  article-title: Pancreatic neuropathy and neuropathic pain–a comprehensive pathomorphological study of 546 cases
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.09.029
  contributor:
    fullname: GO Ceyhan
– volume: 130
  start-page: 6049
  year: 2003
  ident: ref9
  article-title: Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis
  publication-title: Development
  doi: 10.1242/dev.00837
  contributor:
    fullname: J Legg
– volume: 2
  start-page: 164
  year: 2010
  ident: ref10
  article-title: Isolated human islets contain a distinct population of mesenchymal stem cells
  publication-title: Islets
  doi: 10.4161/isl.2.3.11449
  contributor:
    fullname: F Carlotti
– volume: 107
  start-page: 75
  year: 2010
  ident: ref51
  article-title: Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0912589107
  contributor:
    fullname: M Rovira
– volume: 101
  start-page: 465
  year: 1991
  ident: ref33
  article-title: Pancreatic lesions in the von Hippel-Lindau syndrome
  publication-title: Gastroenterology
  doi: 10.1016/0016-5085(91)90026-H
  contributor:
    fullname: HP Neumann
– volume: 157
  start-page: 1615
  year: 2000
  ident: ref34
  article-title: Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)64799-2
  contributor:
    fullname: VH Mohr
– volume: 122
  start-page: 495
  year: 2011
  ident: ref14
  article-title: Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-011-0867-2
  contributor:
    fullname: A Svendsen
– volume: 258
  start-page: 141
  year: 2013
  ident: ref39
  article-title: Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e31828cd008
  contributor:
    fullname: N Ideno
– volume: 17
  start-page: 500
  year: 2011
  ident: ref38
  article-title: Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
  publication-title: Nat Med
  doi: 10.1038/nm.2344
  contributor:
    fullname: EA Collisson
– volume: 107
  start-page: 14182
  year: 2010
  ident: ref42
  article-title: HIF-2alpha deletion promotes Kras-driven lung tumor development
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1001296107
  contributor:
    fullname: J Mazumdar
– volume: 38
  start-page: 251
  year: 2006
  ident: ref18
  article-title: Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse
  publication-title: Ophthalmic Res
  doi: 10.1159/000094833
  contributor:
    fullname: U Ozerdem
– volume: 445
  start-page: 236
  year: 2004
  ident: ref56
  article-title: A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile
  publication-title: Virchows Arch
  doi: 10.1007/s00428-004-1053-x
  contributor:
    fullname: P Monti
– volume: 3
  start-page: 245
  year: 1996
  ident: ref8
  article-title: The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells
  publication-title: Perspect Dev Neurobiol
  contributor:
    fullname: JM Levine
– volume: 4
  start-page: 1527
  year: 2013
  ident: ref63
  article-title: Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.1291
  contributor:
    fullname: A Poli
– volume: 159
  start-page: 2017
  year: 2001
  ident: ref61
  article-title: STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63053-2
  contributor:
    fullname: N Sato
– volume: 8
  start-page: e84883
  year: 2013
  ident: ref19
  article-title: Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0084883
  contributor:
    fullname: F Girolamo
– volume: 254
  start-page: 311
  year: 2011
  ident: ref1
  article-title: Pancreatic cancer surgery in the new millennium: better prediction of outcome
  publication-title: Ann Surg
  doi: 10.1097/SLA.0b013e31821fd334
  contributor:
    fullname: W Hartwig
– volume: 60
  start-page: 1712
  year: 2011
  ident: ref27
  article-title: Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes
  publication-title: Gut
  doi: 10.1136/gut.2010.232272
  contributor:
    fullname: M Mino-Kenudson
– volume: 87
  start-page: 871
  year: 2009
  ident: ref53
  article-title: Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression
  publication-title: J Mol Med (Berl)
  doi: 10.1007/s00109-009-0504-x
  contributor:
    fullname: MS Wiesener
– volume: 12
  start-page: 9
  year: 2012
  ident: ref40
  article-title: HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3183
  contributor:
    fullname: B Keith
– volume: 18
  start-page: 2395
  year: 2012
  ident: ref4
  article-title: Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer
  publication-title: Curr Pharm Des
  doi: 10.2174/13816128112092395
  contributor:
    fullname: H Liu
– volume: 21
  start-page: 193
  year: 2011
  ident: ref6
  article-title: Pericytes: developmental, physiological, and pathological perspectives, problems, and promises
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2011.07.001
  contributor:
    fullname: A Armulik
– year: 2012
  ident: ref13
  article-title: NG2-mediated Rho activation promotes amoeboid invasiveness of cancer cells
  publication-title: Eur J Cell Biol
  contributor:
    fullname: D Pankova
– volume: 150
  start-page: 306
  year: 2011
  ident: ref32
  article-title: Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer
  publication-title: Surgery
  doi: 10.1016/j.surg.2011.05.011
  contributor:
    fullname: H Arafat
– volume: 28
  start-page: 2414
  year: 2008
  ident: ref35
  article-title: Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01621-07
  contributor:
    fullname: AF Hezel
– volume: 215
  start-page: 195
  year: 2008
  ident: ref26
  article-title: Abnormal crosstalk between pancreatic acini and macrophages during the clearance of apoptotic cells in chronic pancreatitis
  publication-title: J Pathol
  doi: 10.1002/path.2348
  contributor:
    fullname: M Bartel
– volume: 51
  start-page: 21
  year: 2011
  ident: ref58
  article-title: In vitro models of pancreatic differentiation using embryonic stem or induced pluripotent stem cells
  publication-title: Congenit Anom (Kyoto)
  doi: 10.1111/j.1741-4520.2010.00307.x
  contributor:
    fullname: Y Higuchi
– volume: 14
  start-page: 141
  year: 2013
  ident: ref29
  article-title: Intraductal papillary mucinous neoplasms of the pancreas (IPMNs): epidemiology, diagnosis and future aspects
  publication-title: JOP
  contributor:
    fullname: F Konstantinou
– year: 2014
  ident: ref30
  article-title: Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas
  publication-title: J Pathol
  contributor:
    fullname: E Amato
– volume: 115
  start-page: 421
  year: 1998
  ident: ref22
  article-title: Identification, culture, and characterization of pancreatic stellate cells in rats and humans
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(98)70209-4
  contributor:
    fullname: MG Bachem
– volume: 105
  start-page: 18913
  year: 2008
  ident: ref47
  article-title: Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0810097105
  contributor:
    fullname: N Habbe
– volume: 60
  start-page: 861
  year: 2011
  ident: ref21
  article-title: Stromal biology and therapy in pancreatic cancer
  publication-title: Gut
  doi: 10.1136/gut.2010.226092
  contributor:
    fullname: A Neesse
– volume: 27
  start-page: 5182
  year: 2008
  ident: ref15
  article-title: The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
  publication-title: Oncogene
  doi: 10.1038/onc.2008.157
  contributor:
    fullname: M Chekenya
– volume: 8
  start-page: 185
  year: 2005
  ident: ref48
  article-title: Pten constrains centroacinar cell expansion and malignant transformation in the pancreas
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.07.015
  contributor:
    fullname: BZ Stanger
– volume: 16
  start-page: 686
  year: 2003
  ident: ref62
  article-title: Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms
  publication-title: Mod Pathol
  doi: 10.1097/01.MP.0000075645.97329.86
  contributor:
    fullname: F Sahin
– volume: 46
  start-page: 4365
  year: 2005
  ident: ref17
  article-title: In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.05-0559
  contributor:
    fullname: Y Li
– volume: 12
  start-page: 183
  year: 2012
  ident: ref28
  article-title: International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
  publication-title: Pancreatology
  doi: 10.1016/j.pan.2012.04.004
  contributor:
    fullname: M Tanaka
– volume: 10
  start-page: 4776
  year: 2004
  ident: ref24
  article-title: Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-1190-03
  contributor:
    fullname: J Koninger
– volume: 148
  start-page: 1763
  year: 1996
  ident: ref25
  article-title: Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16
  publication-title: The American journal of pathology
  contributor:
    fullname: T Furukawa
– volume: 9
  start-page: e1001143
  year: 2011
  ident: ref57
  article-title: Pancreatic mesenchyme regulates epithelial organogenesis throughout development
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.1001143
  contributor:
    fullname: L Landsman
– volume: 226
  start-page: 723
  year: 2012
  ident: ref49
  article-title: Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues
  publication-title: J Pathol
  doi: 10.1002/path.3017
  contributor:
    fullname: M Aichler
– volume: 133
  start-page: 1999
  year: 2007
  ident: ref45
  article-title: In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.09.009
  contributor:
    fullname: O Strobel
SSID ssj0053866
Score 2.289422
Snippet CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect...
CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (s CSPG4 ) might circulate and reflect...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e100178
SubjectTerms Aberration
Adenocarcinoma, Mucinous - genetics
Adenocarcinoma, Mucinous - metabolism
Adenocarcinoma, Mucinous - pathology
Adolescent
Adult
Aged
Aged, 80 and over
Benign
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Blotting, Western
Carcinoma
Carcinoma, Pancreatic Ductal - genetics
Carcinoma, Pancreatic Ductal - metabolism
Carcinoma, Pancreatic Ductal - pathology
Carcinoma, Papillary - genetics
Carcinoma, Papillary - metabolism
Carcinoma, Papillary - pathology
Chondroitin sulfate
Chondroitin Sulfate Proteoglycans - genetics
Chondroitin Sulfate Proteoglycans - metabolism
Cloning
Cystadenoma, Serous - genetics
Cystadenoma, Serous - metabolism
Cystadenoma, Serous - pathology
Diagnostic systems
Discordance
Enzyme-Linked Immunosorbent Assay
Epithelial cells
Exploration
Female
Flow Cytometry
Fluorescent Antibody Technique
Follow-Up Studies
Hospitals
Humans
Hypoxia
Hypoxia - genetics
Hypoxia - pathology
Immunoenzyme Techniques
Immunoglobulins
Immunohistochemistry
In vitro methods and tests
Invasiveness
Male
Medicine and Health Sciences
Melanoma
Membrane Proteins - genetics
Membrane Proteins - metabolism
Mesenchyme
Middle Aged
Mutation
Neoplasia
Neoplasm Staging
Neoplasms
Pancreas
Pancreatic cancer
Pancreatic diseases
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
Pancreatitis
Patients
Pericytes
Polarity
Prognosis
Real-Time Polymerase Chain Reaction
Restoration
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - genetics
Shedding
Signaling
siRNA
Stroma
Sulfates
Surgery
Tissue Array Analysis
Tumor cell lines
Tumor cells
Tumor Cells, Cultured
Tumors
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZgT1wQ5dWUAgYhAYe0TuK1nWNZWsoFEAuIm-U4TnelbbJabxD998zE2YigSnDgGk-iZF7-Rpn5TMgLwStbVkzFvKhMzG0uIKRSMIiwgEcNuIjF4eTzufzwXb09RZqc4agv7AkL9MBBccdTyOIAAarCsoxP81IxBYVPWVo5zZ3KAzRiYldMhRwMUSxEPyiXyeS4t8vRuqndEUu6M-lHG1HH1z9k5cl61fjrIOefnZO_bUVnd8jtHkPSk_Due-SGq--SvT5KPX3VU0m_vkf0bNEgI8Fyu6ypb1cVIEvaUTM0F6sr0CqdzT-949R4amjd_HArurhaNz-XJvbY2Y65kF5iB8-GwhMgcwSQaem2vWw2_j75enb6ZXYe90cqxKAvtY1FavHPI4AYbqRzqqhUUXBACVykBirlwvLcMeWcdJLnaSkz5JuHfF4pkTFusgdkUoMS9wmdqiJnRiaOS-T0MwUvs8KpEkm8TJKJiMQ7_ep1YM7Q3e8zCRVHUJRGe-jeHhF5g0YYZJH3ursA3qB7b9B_84aIPEUT6jBEOkSvPuFQyeIkTBKR550Ecl_U2FxzYVrv9fuP3_5BaP55JPSyF6oacAZr-oEG-Cbk1BpJHo4kIYLtaHkfHW6nFa9hFxLwYVOVwp07J7x--dmwjA_FhrnaNW0nA4U6TxmPyMPgs4NmoeLOALWyiMiRN49UP16pl4uOehzgPRSg6cH_sNUjcgvQJ8e-u0Qcksl207rH5KYv2yddMP8C8mZN6w
  priority: 102
  providerName: Directory of Open Access Journals
Title Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors
URI https://www.ncbi.nlm.nih.gov/pubmed/24932730
https://www.proquest.com/docview/1536089582
https://search.proquest.com/docview/1537174204
https://pubmed.ncbi.nlm.nih.gov/PMC4059742
https://doaj.org/article/5cee059fbc03459d808978ddc759e89a
http://dx.doi.org/10.1371/journal.pone.0100178
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdYT1wQ42sZYxiEBBzS5sO1neMoG-XAqOhA3CLHcbpKbVI1DWL_Pe85TrWgHRDX-CWK34f9e_F7vxDyhrNC50UgfZYVymc64RBSERiEa8CjClxEY3PydC4uf8qP50iTM-56YWzRvs6Ww3K1HpbLa1tbuVnrUVcnNpp9mQDIABgcjQ7IAWDDLkVvl18IYM5dj1wswpEzyXBTlWYYhPZ39MgAzAC4CKx9vrUdWdb-_do82Kyq-i7g-Xf95K0N6eIheeCQJD1r3_iQ3DPlI3LoYrWm7xyh9PvHJJ1cV8hLsNwtSzpvVgXgSzpDgoZqsboB3dLJfPaJUVVTRS-rX2ZFpzeb6vdS-XOsb8cVkWJTj9lSeMIMHMVCTU2vmnW1rZ-Q7xfnV5Op736s4GtID3Y-jzSePwKUYUoYI7NCZhkDrMB4pCBfzjRLTCCNEUawJMpFjKzzsKoXkscBU_FTMihBn0eEjmWWBEqEhglk9lMZy-PMyBypvFQYc4_4nX7TTcufkdpDNAF5R6uoFE2TOtN45AMaYS-L7Nf2QrVdpM4H0jHs7OACRaaDmI2TXAYSkuE8h9klRibKIy_RhGnbSrqP4fSMQT6L_TChR15bCWTAKLHEZqGauk4_f_3xD0Lzbz2ht06oqMAZtHJtDTAnZNbqSZ70JCGOdW_4CB2u00qdwl7EYWJjGcGdnRPePfxqP4wPxbK50lSNlYF0nUUB88iz1mf3mu0iwCOi58091fdHIB4tAbmLv-P_vvM5uQ_Ak2HJXchPyGC3bcwLclDnzan9KHJqQ_oPy3dN_g
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RcIALUF41FLogJODgxI_Nen0soSUVbYhIQNxW6_U6tZTYURwj-u-Z8SOqUQ-oV-_Y0s5rv5FnviXkHWeJjhNH2CxKlM10yCGkPDAI14BHFbiIxuHk8SyY_BKfT5AmZ9jOwlRN-zpK-9ly1c_Sy6q3cr3Sg7ZPbDC9GAHIABjsDfbIXYhXx2mL9DoBwyPOmyk5P3AHjVH66zwzfcetLqRHDmAG0CXA7udrB1LF27_Lzr31Mi9ugp7_dlBeO5JOH95yM4_IgwaD0uN6eZ_cMdljst9EeUE_NFTUH58QObrMkdEg3aYZnZXLBJApnSK1Q75YXoFV6Gg2_cKoKqiik_y3WdLx1Tr_kyp7hp3xmEspjgOZDYUvTMHFKpCq6bxc5ZviKflxejIfje3mSgZbQ2Gxtbmn8c8lgCCmAmNElIgoYoAyGPcUVNqRZqFxhDGBCVjoxYGPfPVwHiSC-w5T_jPSy8AOB4QORRQ6KnANC5ATUEUs9iMjYiQBU67PLWK3dpHrmnlDVr_fAqhYakVJNKlsTGqRT2i8nSzyZlcP8s1CNgqXQ8AEoO8k0o7PhmEsHAFldBzD7kIjQmWRIzS9rIdQd9EvjxlUwjhJ41rkbSWB3BkZNucsVFkU8uzbz_8Qmn3vCL1vhJIcnEirZiAC9oScXB3Jw44kZADdWT5AR221Ukg4xThsbCg8eLN13puX3-yW8aPYcJeZvKxkoNBnnsMs8rz29Z1m28ixSNCJgo7quyvg_BV1eePsL2795hG5N55fnMvzs8nXl-Q-wFeGjXsuPyS97aY0r8heEZevq4TwF4_GYpA
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF7RICEuQHnVUOiCkICD49fGXh9L2pAKCBEpFbfVer1OIyW2FceI_ntm_FKNekBw9Y4t7bz2G3nmW0Le-CxRcWJzk0WJNJkKfQgpFwziK8CjElxE4XDydBHMfvCTU6TJ6a76qpr2VbQapuvNMF1dVr2V-UZZbZ-YNf8yBpABMNi18jix9shtiFnbbQv1OgnDI99vJuW8wLEawwzzLNVD26kupUceYAbwJcAO6GuHUsXd32XoQb7Oipvg559dlNeOpcn9_9jQA3KvwaL0uBbZJ7d0-pDsN9Fe0HcNJfX7R0SMLzNkNljtVildlOsEECqdI8VDtlxfgXXoeDH_yKgsqKSz7Kde0-lVnv1aSXOBHfKYUymOBekthS_MwdUqsKroebnJtsVj8n1yej6ems3VDKaCAmNn-q7CP5gAhpgMtOZRwqOIAdpgviuh4o4UC7XNtQ50wEI3DjzkrYdzIeG-ZzPpPSGDFGxxQOiIR6EtA0ezALkBZcRiL9I8RjIw6Xi-QczWNiKvGThE9RsugMqlVpRAs4rGrAb5gAbsZJE_u3qQbZeiUboYATYAnSeRsj02CmNucyin4xh2F2oeSoMcoflFPYzaZQFxzKAixokaxyCvKwnk0EixSWcpy6IQZ18v_kJo8a0n9LYRSjJwJCWbwQjYE3Jz9SQPe5KQCVRv-QCdtdVKIeA082FjI-7Cm60D37z8qlvGj2LjXaqzspKBgp-5NjPI09rfO8220WOQoBcJPdX3VyAAKgrzxuGf_fObR-TO_GQiPp_NPj0ndwHFMuzfc_xDMthtS_2C7BVx-bLKCb8BpX5lEA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chondroitin+sulfate+proteoglycan+CSPG4+as+a+novel+hypoxia-sensitive+marker+in+pancreatic+tumors&rft.jtitle=PloS+one&rft.au=Keleg%2C+Shereen&rft.au=Titov%2C+Alexandr&rft.au=Heller%2C+Anette&rft.au=Giese%2C+Thomas&rft.date=2014-06-16&rft.eissn=1932-6203&rft.volume=9&rft.issue=6&rft.spage=e100178&rft.epage=e100178&rft_id=info:doi/10.1371%2Fjournal.pone.0100178&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon